Covid-19: 100% Himachal Pradesh adults given first dose
India | Aug 30, 2021, 08:48 AM ISTHimachal Pradesh became the first state in the country to complete administering the first dose of COVID-19 vaccine for the 18-plus age group.
Himachal Pradesh became the first state in the country to complete administering the first dose of COVID-19 vaccine for the 18-plus age group.
According to the 7 pm provisional report, more than 65 lakh doses were administered on Saturday.
The ICMR in its recent study has found that the people already infected with Covid-19 while taking a dose of Covaxin have the same or increased antibody response as unaffected people taking two doses of Covaxin.
Taking to Twitter, Prime Minister Narendra Modi said, "record vaccination numbers today! Crossing 1 crore is a momentous feat. Kudos to those getting vaccinated and those making the vaccination drive a success."
Bill Gates congratulated India on Friday as it administered more than 1 crore Covid-19 vaccine doses in one day.
Over 58.86 crore vaccine doses have been provided to the states and Union Territories so far and more than 17.64 lakh doses are in the pipeline, the ministry said in a statement.
The government thinks that this move is feasible now because there are many vaccines available for the people, apart from Covishield and Covaxin, and also because there is a sufficient amount of vaccines available in the country.
An expert panel set up by an institute under the Ministry of Home Affairs (MHA) has predicted that the third wave of COVID-19 can hit the country anytime between September and October and suggested significantly ramping up the vaccination pace.
The judge also said that if efficacy was the reason for the gap, then he was "worried" as he was administered the second dose within 4-6 weeks of the first dose
The government aims to administer one crore doses per day, and its expected vaccine availability between August and December is about 135 crore doses.
The single-shot vaccine of J&J is the second Covid-19 vaccine which has already been approved for the Emergency Use Authorisation (EUA) through the fast-track approval route by the Drug Controller General of India.
The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.
ZyCoV-D vaccine: Zydus Cadila's 3-dose vaccine 'ZyCoV-D' has finally got approval for emergency use by India's central drug authority. The vaccine is the world's first and India's indigenously developed DNA-based vaccine for Covid-19.
In a statement issued on Friday, the BMC said 1,60,240 vaccine doses arrived here on Thursday night, comprising 1.5 lakh Covishield and 10,240 Covaxin vaccines.
An expert panel of India's central drug authority has recommended granting emergency use authorisation to Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D, sources said.
Over 3.86 crore people did not get their second dose of anti-Covid vaccines -- Covishield and Covaxin -- within the stipulated period of time, the government has said in response to an RTI query.
The cumulative number of COVID-19 vaccine doses administered in the country has surpassed 55 crore.
India took 85 days to touch the figure of 10 crores. It then took 45 days to cross the 20 crore-mark, 29 days more to reach 30 crores. India took 24 days to reach 40 crore from 30 crore and then 20 more days to cross 50 crore vaccinations on August 6. It surpassed the 54 crore-mark on August 14.
According to the data shared by the Union Health Ministry on Friday, the country saw a total of 35,743 discharges in the last 24 hours.
Cyrus Poonawalla on Friday strongly affirmed that mixing two different vaccines of COVID-19 is a very risky decision and it is must be discouraged.
Top News
Latest News
